• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化疗后非精原细胞瘤性睾丸肿瘤患者术中计算机断层扫描检测腹膜后间隙残留肿块有效性的评估

The intraoperative assessment of the effectiveness of computed tomography in the detection of the residual mass of the retroperitoneal space in patients with nonseminoma testicular tumors after chemotherapy.

作者信息

Jaszczyński Janusz, Chłosta Piotr, Faron Piotr, Strach Andrzej, Jakubik Piotr, Wilk Wacław, Luczyńska Elżbieta, Anioł Joanna, Skotnicki Piotr, Jakubowicz Jerzy, Stelmach Andrzej

机构信息

Surgical Oncology Clinic, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Cracow, Poland.

出版信息

Pol J Radiol. 2011 Apr;76(2):22-4.

PMID:22802826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3389921/
Abstract

BACKGROUND

The incidence of testicular tumors in Poland accounts for 2.4 new cases per 100.000 men a year. When investigating the incidence with regard to age, we may notice three age ranges with the highest incidence rate: babyhood, 25-40 years of age, and age of about 60 years. A routine examination in patients with testicular cancer after the first course of chemotherapy is computed tomography of the retroperitoneal space which aims to exclude the presence of residual masses and to assess the effectiveness of the treatment.

AIM OF THE STUDY

The assessment of the effectiveness of computed tomography in the intraoperative investigation of patients with nonseminoma testicular tumors after chemotherapy.

MATERIAL/METHOD: This detailed retrospective analysis included 182 men with nonseminoma testicular tumor treated at the Center of Oncology in Cracow, between the yeas 1990-1999. Men with tumors in stage from IA to IIC made up 79.68% of the patients. Twenty patients after chemotherapy, with residual masses in the retroperitoneal cavity revealed in computed tomography, underwent retroperitoneal lymphadenectomy. The investigation was carried out with GE CT spiral scanner before and after intravenous contrast administration.

CONCLUSIONS

Computed tomography is a method of a satisfactory sensitivity in the assessment of residual masses in the retroperitoneal cavity in postchemotherapy patients, as concerns the location of the tumor, its size, number of foci, and the fact whether it can be operated on or not. Together with tumor markers, it allows for a precise qualification to retroperitoneal lymphadenectomy of residual masses in postchemotherapy patients.

摘要

背景

在波兰,睾丸肿瘤的发病率为每年每10万名男性中有2.4例新发病例。在按年龄调查发病率时,我们可能会注意到三个发病率最高的年龄范围:婴儿期、25至40岁以及约60岁。睾丸癌患者在首次化疗疗程后的常规检查是腹膜后间隙的计算机断层扫描,其目的是排除残留肿块的存在并评估治疗效果。

研究目的

评估计算机断层扫描在化疗后非精原细胞瘤性睾丸肿瘤患者术中检查中的有效性。

材料/方法:这项详细的回顾性分析纳入了1990年至1999年间在克拉科夫肿瘤中心接受治疗的182例非精原细胞瘤性睾丸肿瘤男性患者。IA至IIC期肿瘤患者占患者总数的79.68%。20例化疗后计算机断层扫描显示腹膜后腔有残留肿块的患者接受了腹膜后淋巴结清扫术。使用GE螺旋CT扫描仪在静脉注射造影剂前后进行检查。

结论

计算机断层扫描是一种在评估化疗后患者腹膜后腔残留肿块方面具有令人满意敏感性的方法,涉及肿瘤的位置、大小、病灶数量以及是否可进行手术等方面。与肿瘤标志物一起,它能够对化疗后患者残留肿块进行腹膜后淋巴结清扫术的精确评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40a/3389921/2ac3f10e333f/poljradiol-76-2-22-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40a/3389921/4d4c49af3cac/poljradiol-76-2-22-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40a/3389921/2ac3f10e333f/poljradiol-76-2-22-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40a/3389921/4d4c49af3cac/poljradiol-76-2-22-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a40a/3389921/2ac3f10e333f/poljradiol-76-2-22-g003.jpg

相似文献

1
The intraoperative assessment of the effectiveness of computed tomography in the detection of the residual mass of the retroperitoneal space in patients with nonseminoma testicular tumors after chemotherapy.化疗后非精原细胞瘤性睾丸肿瘤患者术中计算机断层扫描检测腹膜后间隙残留肿块有效性的评估
Pol J Radiol. 2011 Apr;76(2):22-4.
2
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group.非精原细胞瘤患者化疗后残留肿瘤行单侧或双侧腹膜后淋巴结清扫?来自瑞典挪威睾丸癌研究组基于人群的 RETROP 映射研究的结果。
Eur Urol Oncol. 2022 Apr;5(2):235-243. doi: 10.1016/j.euo.2021.02.002. Epub 2021 Mar 6.
3
[Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].[¹⁸F]-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描(¹⁸FDG-PET)在睾丸肿瘤腹膜后淋巴结转移诊断中的应用
Urologe A. 1998 Nov;37(6):609-20. doi: 10.1007/s001200050223.
4
[Retroperitoneal lymphadenectomy in disseminated non-seminoma germinogenic testicular tumors after chemotherapy in patients with elevated serum tumor markers].血清肿瘤标志物升高患者化疗后播散性非精原细胞瘤性睾丸肿瘤的腹膜后淋巴结清扫术
Urologiia. 2010 May-Jun(3):41-7.
5
Clinical and radiological correlation of retroperitoneal metastasis from nonseminomatous testicular cancer treated with chemotherapy.
Eur J Cancer Clin Oncol. 1989 Jan;25(1):35-43. doi: 10.1016/0277-5379(89)90048-5.
6
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in Nonseminoma.新模型预测非精原细胞瘤化疗后残留腹膜后肿块的良性组织学。
Eur Urol Focus. 2018 Dec;4(6):995-1001. doi: 10.1016/j.euf.2018.01.015. Epub 2018 Feb 7.
7
[Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].[化疗后腹膜后淋巴结清扫术的临床结果及预测睾丸晚期非精原细胞瘤腹膜后组织学情况]
Zhonghua Wai Ke Za Zhi. 2017 Aug 1;55(8):603-607. doi: 10.3760/cma.j.issn.0529-5815.2017.08.010.
8
Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?对于非精原细胞瘤性睾丸癌且残留肿瘤肿块极小的患者,化疗后腹膜后手术是否必要?
J Clin Oncol. 1992 Apr;10(4):569-73. doi: 10.1200/JCO.1992.10.4.569.
9
Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor.化疗后非精原细胞瘤生殖细胞睾丸肿瘤残留肿块的腹膜后淋巴结清扫术。
World J Surg Oncol. 2010 Nov 9;8:97. doi: 10.1186/1477-7819-8-97.
10
Contemporary management of postchemotherapy testis cancer.化疗后睾丸生殖细胞肿瘤的当代治疗。
Eur Urol. 2012 Nov;62(5):867-76. doi: 10.1016/j.eururo.2012.08.014. Epub 2012 Aug 20.

本文引用的文献

1
Postchemotherapy laparoscopic retroperitoneal lymph node dissection in nonseminomatous germ-cell tumor.非精原细胞性生殖细胞肿瘤化疗后腹腔镜腹膜后淋巴结清扫术
J Endourol. 2009 Apr;23(4):645-50. doi: 10.1089/end.2008.0423.
2
Guidelines on testicular cancer.睾丸癌指南。
Eur Urol. 2005 Dec;48(6):885-94. doi: 10.1016/j.eururo.2005.06.019. Epub 2005 Jul 18.
3
[Lymphadenectomy for testicular cancer. Diagnostic and prognostic significance as well as therapeutic benefit].[睾丸癌的淋巴结清扫术。诊断和预后意义以及治疗益处]
Urologe A. 2005 Jun;44(6):652-6. doi: 10.1007/s00120-005-0824-6.
4
[Surgery of retroperitoneal residual mass].[腹膜后残留肿块的手术治疗]
Arch Esp Urol. 2000 Jul-Aug;53(6):535-46.
5
Proper staging techniques in testicular cancer patients.睾丸癌患者的恰当分期技术。
Tech Urol. 1995 Fall;1(3):126-32.
6
Retroperitoneal imaging with third and fourth generation computed axial tomography in clinical stage I nonseminomatous germ cell tumors.在临床I期非精原细胞性生殖细胞肿瘤中使用第三代和第四代计算机轴向断层扫描进行腹膜后成像。
Urology. 1994 Oct;44(4):548-52. doi: 10.1016/s0090-4295(94)80056-1.
7
Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology.
AJR Am J Roentgenol. 1985 Oct;145(4):743-6. doi: 10.2214/ajr.145.4.743.